title: A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.
authors.affiliation: Psychiatry Service, Veterans Administration Medical Center, Washington, D.C. 20422.
authors.forename: S I
authors.initials: SI
authors.lastname: Deutsch
authors.forename: J
authors.initials: J
authors.lastname: Mastropaolo
authors.forename: B L
authors.initials: BL
authors.lastname: Schwartz
authors.forename: R B
authors.initials: RB
authors.lastname: Rosse
authors.forename: J M
authors.initials: JM
authors.lastname: Morihisa
mesh_terms: D005971:Glutamates / Q000502:physiology*; D005998:Glycine / Q000494:pharmacology*; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000502:physiology*; D012559:Schizophrenia / Q000503:physiopathology*; D009435:Synaptic Transmission
chemical_list: D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D005998:Glycine